A detailed history of High Tower Advisors, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, High Tower Advisors, LLC holds 30,538 shares of BMRN stock, worth $2.03 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,538
Previous 2,695 1033.14%
Holding current value
$2.03 Million
Previous $221,000 871.04%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$69.02 - $93.84 $1.92 Million - $2.61 Million
27,843 Added 1033.14%
30,538 $2.15 Million
Q2 2024

Aug 13, 2024

SELL
$74.43 - $92.22 $331,511 - $410,747
-4,454 Reduced 62.3%
2,695 $221,000
Q1 2024

May 06, 2024

SELL
$83.81 - $99.0 $93,112 - $109,989
-1,111 Reduced 13.45%
7,149 $624,000
Q4 2023

Feb 12, 2024

BUY
$76.22 - $98.51 $42,911 - $55,461
563 Added 7.31%
8,260 $796,000
Q3 2023

Nov 08, 2023

BUY
$85.07 - $94.48 $236,154 - $262,276
2,776 Added 56.41%
7,697 $681,000
Q2 2023

Aug 14, 2023

BUY
$86.68 - $100.3 $2,167 - $2,507
25 Added 0.51%
4,921 $426,000
Q1 2023

May 11, 2023

SELL
$87.74 - $117.27 $19,039 - $25,447
-217 Reduced 4.24%
4,896 $476,000
Q4 2022

Feb 08, 2023

BUY
$80.93 - $108.63 $25,492 - $34,218
315 Added 6.57%
5,113 $529,000
Q3 2022

Nov 09, 2022

SELL
$82.16 - $96.94 $418,276 - $493,521
-5,091 Reduced 51.48%
4,798 $406,000
Q2 2022

Aug 10, 2022

SELL
$71.48 - $86.85 $41,172 - $50,025
-576 Reduced 5.5%
9,889 $817,000
Q1 2022

May 12, 2022

SELL
$74.28 - $92.69 $768,500 - $958,970
-10,346 Reduced 49.71%
10,465 $808,000
Q4 2021

Feb 10, 2022

BUY
$71.72 - $91.47 $456,210 - $581,840
6,361 Added 44.02%
20,811 $1.84 Million
Q3 2021

Nov 12, 2021

BUY
$74.77 - $85.47 $743,139 - $849,486
9,939 Added 220.33%
14,450 $1.12 Million
Q2 2021

Aug 06, 2021

BUY
$75.51 - $84.79 $24,087 - $27,048
319 Added 7.61%
4,511 $378,000
Q1 2021

May 10, 2021

BUY
$74.73 - $90.69 $13,376 - $16,233
179 Added 4.46%
4,192 $319,000
Q4 2020

Feb 10, 2021

BUY
$72.61 - $90.2 $291,383 - $361,972
4,013 New
4,013 $353,000
Q3 2020

Nov 13, 2020

SELL
$71.87 - $131.03 $166,019 - $302,679
-2,310 Closed
0 $0
Q2 2020

Aug 10, 2020

SELL
$79.55 - $124.22 $7,000 - $10,931
-88 Reduced 3.67%
2,310 $281,000
Q1 2020

May 21, 2020

SELL
$71.37 - $96.85 $6,494 - $8,813
-91 Reduced 3.66%
2,398 $201,000
Q4 2019

Feb 14, 2020

BUY
$64.27 - $86.37 $159,968 - $214,974
2,489 New
2,489 $208,000
Q3 2019

Nov 12, 2019

SELL
$67.4 - $85.11 $340,437 - $429,890
-5,051 Closed
0 $0
Q2 2019

Aug 13, 2019

SELL
$80.35 - $93.9 $77,939 - $91,083
-970 Reduced 16.11%
5,051 $438,000
Q1 2019

May 15, 2019

SELL
$84.2 - $98.62 $11,198 - $13,116
-133 Reduced 2.16%
6,021 $535,000
Q4 2018

Feb 14, 2019

BUY
$80.14 - $106.07 $84,707 - $112,115
1,057 Added 20.74%
6,154 $530,000
Q3 2018

Nov 09, 2018

BUY
$93.92 - $105.72 $3,381 - $3,805
36 Added 0.71%
5,097 $493,000
Q2 2018

Aug 14, 2018

BUY
$76.01 - $99.03 $136,894 - $178,353
1,801 Added 55.25%
5,061 $479,000
Q1 2018

May 15, 2018

SELL
$77.67 - $92.63 $41,398 - $49,371
-533 Reduced 14.05%
3,260 $264,000
Q4 2017

Feb 14, 2018

BUY
$80.76 - $95.13 $97,396 - $114,726
1,206 Added 46.62%
3,793 $339,000
Q3 2017

Nov 14, 2017

SELL
$80.6 - $94.95 $40,783 - $48,044
-506 Reduced 16.36%
2,587 $244,000
Q2 2017

Aug 14, 2017

BUY
N/A
3,093
3,093 $282,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.